The National Institute for Health and Care Research (NIHR), Innovate UK, the Advanced Therapy Treatment Centre Network and the Cell and Gene Therapy Catapult (CGT Catapult) today announce a £17.9 million strategic initiative to enhance the UK environment for advanced therapy medicinal product (ATMP) clinical trials and to keep the UK as a location of choice for advanced therapy research. The initiative will provide a further four years of funding for the Advanced Therapy Treatment Centre Network (ATTC Network). The funding will come from NIHR, Innovate UK will provide oversight of the funds and CGT Catapult provide co-ordination of the network.